Stochastic modelling of tumorigenesis in p53 deficient mice

British Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 243-252

  Mao, J H ^a   Lindsay, K A ^a   Balmain, A ^a   Wheldon, T E ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Caretaker gene; Gatekeeper gene; Multigate model; Multistage model; p53; Transgenic mouse

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CELL MUTANT; CELL VIABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; STOCHASTIC MODEL; TUMOR SUPPRESSOR GENE;

EID: 0031984654     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.40     Document Type: Article

References (33)

1. Bodmer WF and Thomlinson I (1996) Population genetics of tumours. CIBA Foundation Symposia 197: 181-189
2. Bouffler SD, Kemp CJ, Balmain A and Cox R (1995) Spontaneous and ionizing radiation-induced chromosomal-abnormalities in p53-deficient mice. Cancer Res 55: 3883-3889
3. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221
4. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA, Park SH, Thompson T, Ford RJ and Bradley A (1995) Effects ot genetic background on tumorigenesis in p53-deficient mice. Mol Carcinogen 14: 16-22
5. Fowlis DJ and Balmain A (1993) Oncogenes and tumour suppressor genes in transgenic mouse models ot neoplasia. Eur J Cancer 29A: 638-645
6. Havre PA, Yuan JL, Hedrick L, Cho KR and Glazer PM (1995) p53 inactivation by HPV 16 E6 results in increased mutagenesis in human cells. Cancer Res 55: 4420-4424
7. Harvey M, McArthur MJ, Montgomery CA, Butel JS, Bradley A and Donehower LA (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet 5: 225-229
8. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467
9. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53
10. Hursting SD, Perkins SN and Phang JM (1994) Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc Natl Acad Sci USA 91: 7036-7040
11. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA (1994) Tumour spectrum analysis in p53-mutant mice. Current Biol 4: 1-7
12. Kemp CJ, Wheldon T and Balmain A (1994) p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet 8: 66-69
13. Kinzler KW and Vogelstein B (1997) Gatekeepers and caretakers. Nature 386: 761-763
14. Knudson AG (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
15. Knudson AG (1996) Hereditary cancer - 2 Hits revisited. J Cancer Res Clin Oncol 122: 135-140
16. Lane DP (1992) p53, guardian of the genome. Nature 358: 15-16
17. Lane DP (1994) The regulation of p53 function - Steiner-award lecture. Int J Cancer 57: 623-627
18. Livingstone LR, White A, Sprouse J, Livanos H, Jacks T and Tlsty T (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935
19. Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075-3079
20. Mao JH and Wheldon TE (1995) A stochastic model for multistage tumorigenesis in developing and adult mice. Math Biosci 129: 95-110
21. Moolgavkar SH and Knudson AG (1981) Mutation and cancer: A model for human carcinogenesis. J Natl Cancer Inst 66: 1037-1052
22. Moolgavkar SH and Luebeck EG (1992) Multistage carcinogenesis: Population-based model for colon cancer. J Natl Cancer Inst 84: 610-618
23. Moolgavkar SH and Venzon D (1979) Two-event models for carcinogenesis: Incidence curves for childhood and adult tumours. Math Biosci 47: 55-77
24. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SEM, Salter DM, Bird CC, Wyllie AH, Hooper ML and Clarke AR (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9: 603-609
25. Reitmar AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri M, Waterhouse P, Mittrucker HW, Wakeham A, Liu B, Thomason A, Griesser H, Gallinger S, Ballhausen WG, Fishel R and Mak TW (1995) MSH2 mice are viable and susceptible to lymphoid tumours. Nature Genet 11: 64-70
26. Renan MJ (1993) How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinogen 7: 139-146
27. Sands AT, Suraokar MB, Sanchez A, Marth JE, Donehower LA and Bradley A (1995) p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc Natl Acad Sci USA 92: S517-8521
28. Sherman CD and Portier CJ (1994) The multipath/multistage model of carcinogenesis. Inform Biom Epidemiol Med Biol 25: 2511-254
29. Tan WY (1991) Stochastic Models of Carcinogenesis. Marcel Dekker: New York
30. Vogelstein B (1990) A deadly inheritance. Nature 348: 681-682
31. Vogelstein B and Kinzler KW (1993) The multistep nature of cancer. Trend Genet 9: 138-141
32. Xia F, Wang X, Wang YH, Tsang NM, Yandll DW, Kelsey KT and Liber HL (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res 55: 12-15
33. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Hall GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948